Skip to search formSkip to main contentSkip to account menu

Macugen

National Institutes of Health

Related topics

Related topics

4 relations
0.09 ML pegaptanib 3.33 MG/ML Prefilled Syringe [Macugen]pegaptanib Prefilled Syringe [Macugen]

Broader (2)

Pegaptanib Sodiumpegaptanib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Finding the Optimal Treatment Plan for Exudative AMD: A review of Current Anti-VEGF Dosing Regimens
Age-related macular degeneration (AMD) is the leading cause of severe central visual acuity loss in people over 50 years of age… 
2010
2010
Comparison of Combined Therapy of Intravitreal Injection of Avastin and Macugen versus Mono-Therapy. The MAAM Study-a Pilot Study
2008
2008
Pegaptanib Sodium (Macugen) as an Adjunct in Proliferative Diabetic Retinopathy Refractory to Laser Treatment
2007
2007
Safety of Macugen (pegaptanib sodium) for neovascular age-related macular degeneration (NV-AMD). After 3 years of experience
Purpose: To evaluate the safety of Macugen in the treatment of NV-AMD after 3 years experience in the V.I.S.I.O.N. trial… 
2007
2007
The suppression of early angiogenic markers by the antiangiogenic aptamer Macugen® is dose dependent
The suppression of early angiogenic markers by the antiangiogenic aptamer Macugen R is dose dependent 
2006
2006
Short-Term Intraocular Pressure Trends Following Intravitreal Pegaptanib (Macugen) Injection
2006
2006
Macugen in Retinopathy of Prematurity
2006
2006
Avastin Enhancement and Macugen Maintenance Therapy for Exudative Age Related Macular Degeneration
2006
2006
Macugen: more efficacious when used early in AMD?
Until recently, treatment options for neovascular (wet) AMD have been limited. Thermal laser photocoagulation - a destructive… 
2005
2005
FDA Approves Macugen
The FDA approved pegaptanib sodium injection (Macugen, Eyetech Pharmaceuticals and Pfizer Ophthalmics) for the treatment of…